It obstructs the nuclear translocation of YAP/TAZ, leading to apoptosis in breast cancer (MCF-7 and MDA-MB-231) cells [908], and mitigates migration and invasion in breast cancer (MDA-MB-231) cells by reducing oxidative stress, suppressing NLRP3 inflammasome activation, enhancing mitochondrial fusion, and down-regulating RAC1 mRNA [927, 929]. Here, NLRP3 is linked to breast cancer.